Table 2.
Synthetic oligonucleotides used in this study.
| Name | Oligonucleotide sequencea |
| Oligonucleotides based on omp35 | |
| O1 | 5'-TGCTCGAGGGGCGGGTAAACGTAAACTCA-3' |
| O2 | 5'-TGCTCGAGCATGGCGCCTCACCTACCT-3' |
| O3 | 5'-ATTGCGATCGATATAACCGTTGGCGATCTT-3' |
| O4 | 5'-ATTGCGATCGATTAACAAAGGTATTGCGGGTAT-3' |
| O5 | 5'-TTTAGAGAAGCGGTAGTCAGC-3' |
| O6 | 5'-ATCGCCAACGGTTATGAT-3' |
| O7 | 5'-ACGCCATATCGAGTTTACAT-3' |
| Oligonucleotide based on Km r gene | |
| K1 | 5'-ATTGCGATCGATTTATGCTTGTAAACCGTT-3' |
| Oligonucleotides based on cat gene | |
| C1 | 5'-CAGACGGCATGATGAACCTGAATC-3' |
| C2 | 5'-CCACCGTTGATATATCCCAATGGC-3' |
aThe underlined regions indicate the following restriction endonuclease sites engineered into the oligonucleotides: XhoI sites in O1 and O2 and ClaI sites in O3, O4, and K1.